Modified MMAF

Modify Date: 2024-01-12 10:52:46

Modified MMAF Structure
Modified MMAF structure
Common Name Modified MMAF
CAS Number 1352202-47-1 Molecular Weight 840.10
Density N/A Boiling Point N/A
Molecular Formula C45H73N7O8 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Modified MMAF


Modified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted treatment of cancer[1].

 Names

Name Modified MMAF

 Modified MMAF Biological Activity

Description Modified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted treatment of cancer[1].
Related Catalog
In Vitro MMAF inhibits anaplastic large cell lymphoma Karpas 299, breast carcinoma H3396, renal cell carcinoma 786-O and Caki-1 cells with IC50s of 119, 105, 257 and 200 nM in vitro cytotoxicity assay[2].
References

[1]. Polson AG, et al. Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection [published correction appears in Cancer Res. 2010 Feb 1;70(3):1275. Slaga, Dion S [added]]. Cancer Res. 2009;69(6):2358-2364.

[2]. Doronina SO, et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem. 2006;17(1):114-124.

 Chemical & Physical Properties

Molecular Formula C45H73N7O8
Molecular Weight 840.10